Perioperative management of malignant pheochromocytoma with coronary artery disease- A case report

Sambhunath Das

Abstract


Presence of malignant pheochromocytoma tumor and coronary artery disease is extremely rare and carry high perioperative risk. The postoperative morbidity and mortality are increased by many folds. In the reference case, adrenal tumor had infiltrated to inferior vena cava (IVC), liver and right kidney. He had associated coronary artery disease. We describe the management of a patient with malignant tumor of adrenal gland undergoing surgical removal with all arrangements for coronary artery bypass grafting and intrathoracic extraction of tumor from IVC. It is a rare example of cardiac patient for non-cardiac surgery.

Keywords: Cardiac patient for non-cardiac surgery, Coronary artery disease, Malignant pheochromocytoma, Pheochromocytoma.


Full Text:

PDF

References


Baillargeon JP, Pek B, Teijeira J, Poisson J, Van Rossum N, Langlois MF. Combined surgery for coronary artery disease and pheochromocytoma. Can J Anaesth 2000;47(7):647-52.

Cohn SL. The cardiac consult for patients undergoing non-cardiac surgery. Heart 2016;102:1322-32.

Rachel S B, Eric K O, David S B, John M C. Revised Cardiac Risk Index as a Predictor for Myocardial Infarction and Cardiac Arrest Following Posterior Lumbar Decompression. Spine 2019;44:E187-E193

Manger WM. An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges. Ann N Y Acad Sci 2006;1073:1–20.

Strong VE, Kennedy T, Al Ahmadie H, Tang L, Coleman J, Fong Y, Brennan M, Ghossein RA. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. Surg 2008;143:759–68.

Kulkarni MM, Khandeparkar SG, Deshmukh SD. Risk Stratification in Paragangliomas with PASS (Pheochromocytoma of the Adrenal Gland Scaled Score) and Immunohistochemical Markers. J Clin Diagn Res 2016;10(9):EC01–EC04.

Eisenhofer G, Bornstein SR, Brouwers FM. Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 2004;11:423–36.

Adjallé R, Plouin PF, Pacak K, Lehnert H. Treatment of malignant pheochromocytoma. Horm Metab Res 2009;41(9):687–96.